| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Departments of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, Missouri, USA;
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; and
Department of Biochemistry, Taipei Medical University, Taipei, Taiwan
1 Correspondence: Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, 1402 South Grand Blvd., St. Louis, MO 63104, USA. E-mail: huangss{at}slu.edu or huangjs{at}slu.edu
The type V TGF-ß receptor (TßR-V)/IGFBP-3 receptor mediates the IGF-independent growth inhibition induced by IGFBP-3. It also mediates the growth inhibitory response to TGF-ß1 in concert with other TGF-ß receptor types, and its loss may contribute to the malignant phenotype of human carcinoma cells. Here we demonstrate that TßR-V is identical to LRP-1/
2M receptor as shown by MALDI-TOF analysis of tryptic peptides of TßR-V purified from bovine liver. In addition, 125I-IGFBP-3 affinity-labeled TßR-V in Mv1Lu cells is immunoprecipitated by antibodies to LRP-1 and TßR-V. RAP, an LRP-1 antagonist, inhibits binding of 125I-TGF-ß1 and 125I-IGFBP-3 to TßR-V and diminishes IGFBP-3-induced growth inhibition in Mv1Lu cells. Absent or low levels of LRP-1, as with TßR-V, have been linked to the malignant phenotype of carcinoma cells. Mutagenized Mv1Lu cells selected for reduced expression of LRP-1 have an attenuated growth inhibitory response to TGF-ß1 and IGFBP-3. LRP-1-deficient mouse embryonic fibroblasts lack a growth inhibitory response to TGF-ß1 and IGFBP-3. On the other hand, stable transfection of H1299 human lung carcinoma cells with LRP-1 cDNA restores the growth inhibitory response. These results suggest that the LRP-1/TßR-V/IGFBP-3 receptor is required for the growth inhibitory response to IGFBP-3 and TGF-ß1.—Huang, S. S., Ling, T.-Y., Tseng, W.-F., Huang, Y.-H., Tang, F.-M., Leal, S. M., Huang, J. S. Cellular growth inhibition by IGFBP-3 and TGF-ß1 requires LRP-1.
Key Words: type V TGF-ß receptor • IGFBP-3 receptor • growth inhibition • epithelial cells • carcinogenesis
This article has been cited by other articles:
|
|
 |
|
  C.-L. Chen, W.-H. Hou, I-H. Liu, G. Hsiao, S. S. Huang, and J. S. Huang Inhibitors of clathrin-dependent endocytosis enhance TGF{beta} signaling and responses J. Cell Sci., June 1, 2009; 122(11): 1863 - 1871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Yamada and K.-W. Lee Perspectives in mammalian IGFBP-3 biology: local vs. systemic action Am J Physiol Cell Physiol, May 1, 2009; 296(5): C954 - C976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Zurhove, C. Nakajima, J. Herz, H. H. Bock, and P. May {gamma}-Secretase Limits the Inflammatory Response Through the Processing of LRP1 Sci. Signal., November 25, 2008; 1(47): ra15 - ra15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, and D. K. Strickland LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies Physiol Rev, July 1, 2008; 88(3): 887 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zappala, C. Elbi, J. Edwards, J. Gorenstein, M. M. Rechler, and N. Bhattacharyya Induction of Apoptosis in Human Prostate Cancer Cells by Insulin-Like Growth Factor Binding Protein-3 Does Not Require Binding to Retinoid X Receptor-{alpha} Endocrinology, April 1, 2008; 149(4): 1802 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Dayton and M. E. White Cellular and molecular regulation of muscle growth and development in meat animals J Anim Sci, April 1, 2008; 86(14_suppl): E217 - E225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Chen, I-H. Liu, S. J. Fliesler, X. Han, S. S. Huang, and J. S. Huang Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis J. Cell Sci., October 15, 2007; 120(20): 3509 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-W. Lee, L. J. Cobb, V. Paharkova-Vatchkova, B. Liu, J. Milbrandt, and P. Cohen Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3 Carcinogenesis, August 1, 2007; 28(8): 1653 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cabello-Verrugio and E. Brandan A Novel Modulatory Mechanism of Transforming Growth Factor-beta Signaling through Decorin and LRP-1 J. Biol. Chem., June 29, 2007; 282(26): 18842 - 18850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Brandan, C. Retamal, C. Cabello-Verrugio, and M.-P. Marzolo The Low Density Lipoprotein Receptor-related Protein Functions as an Endocytic Receptor for Decorin J. Biol. Chem., October 20, 2006; 281(42): 31562 - 31571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Muzumdar, X. Ma, S. Fishman, X. Yang, G. Atzmon, P. Vuguin, F. H. Einstein, D. Hwang, P. Cohen, and N. Barzilai Central and Opposing Effects of IGF-I and IGF-Binding Protein-3 on Systemic Insulin Action. Diabetes, October 1, 2006; 55(10): 2788 - 2796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bhattacharyya, K. Pechhold, H. Shahjee, G. Zappala, C. Elbi, B. Raaka, M. Wiench, J. Hong, and M. M. Rechler Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus J. Biol. Chem., August 25, 2006; 281(34): 24588 - 24601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cohen Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology, May 1, 2006; 147(5): 2109 - 2111. [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Chen, S. S. Huang, and J. S. Huang Cellular Heparan Sulfate Negatively Modulates Transforming Growth Factor-beta1 (TGF-beta1) Responsiveness in Epithelial Cells J. Biol. Chem., April 28, 2006; 281(17): 11506 - 11514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Lee, M. Takahashi, K. Honke, E. Miyoshi, D. Osumi, H. Sakiyama, A. Ekuni, X. Wang, S. Inoue, J. Gu, et al. Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in fut8-/- mice. J. Biochem., March 1, 2006; 139(3): 391 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. B. Johnson, R. E. Hammer, and J. Herz Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice Hum. Mol. Genet., November 15, 2005; 14(22): 3523 - 3538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Waghabi, M. Keramidas, S. Bailly, W. Degrave, L. Mendonca-Lima, M. d. N. C. Soeiro, M. d. N. L. Meirelles, S. Paciornik, T. C. Araujo-Jorge, and J.-J. Feige Uptake of Host Cell Transforming Growth Factor-{beta} by Trypanosoma cruzi Amastigotes in Cardiomyocytes: Potential Role in Parasite Cycle Completion Am. J. Pathol., October 1, 2005; 167(4): 993 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L O'Rear, L Longobardi, M Torello, B K Law, H L Moses, F Chiarelli, and A Spagnoli Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-{beta} in mesenchymal chondroprogenitor cell growth J. Mol. Endocrinol., June 1, 2005; 34(3): 723 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Li, J. Xiang, and C. Duan Insulin-like Growth Factor-binding Protein-3 Plays an Important Role in Regulating Pharyngeal Skeleton and Inner Ear Formation and Differentiation J. Biol. Chem., February 4, 2005; 280(5): 3613 - 3620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. McCarty Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380. [Abstract] [PDF]
|
|
|
|
 |
|
 J. F. Kuemmerle, K. S. Murthy, and J. G. Bowers IGFBP-3 activates TGF-{beta} receptors and directly inhibits growth in human intestinal smooth muscle cells Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G795 - G802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-Y. Ling, C.-L. Chen, Y.-H. Huang, I-H. Liu, S. S. Huang, and J. S. Huang Identification and Characterization of the Acidic pH Binding Sites for Growth Regulatory Ligands of Low Density Lipoprotein Receptor-related Protein-1 J. Biol. Chem., September 10, 2004; 279(37): 38736 - 38748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Salicioni, A. Gaultier, C. Brownlee, M. K. Cheezum, and S. L. Gonias Low Density Lipoprotein Receptor-related Protein-1 Promotes {beta}1 Integrin Maturation and Transport to the Cell Surface J. Biol. Chem., March 12, 2004; 279(11): 10005 - 10012. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
